MTOR and prostate carcinoma: Branched chain amino acids can possibly work as precursors for citrate production (Zhang et al., 2017b), and leucine can act as a sensor for mTOR-pathway activation (Ananieva and Wilkinson, 2018), which is generally regarded as an important pathway in prostate cancer development (Edlind and Hsieh, 2014).